Stock Price
78.88
Daily Change
3.08 4.06%
Monthly
7.41%
Yearly
-19.36%
Q1 Forecast
73.40

Symrise reported EUR2.08B in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Avient USD 739.4M 31M Sep/2025
Chemours USD 1.33B 71M Dec/2025
Corteva USD 3.1B 217M Dec/2025
Covestro EUR -2.22B 5.55B Sep/2025
Symrise EUR 2.08B 118.33M Dec/2024
Victrex GBP 123.9M 200K Dec/2025